WATSON 425 (Aspirin, Butalbital, Caffeine and Codeine Phosphate 325 mg / 50 mg / 40 mg / 30 mg)
Pill with imprint WATSON 425 is Blue & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital, Caffeine and Codeine Phosphate 325 mg / 50 mg / 40 mg / 30 mg. It is supplied by Watson Pharmaceuticals.
Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 425
Aspirin, Butalbital, Caffeine and Codeine Phosphate
- Imprint
- WATSON 425
- Strength
- 325 mg / 50 mg / 40 mg / 30 mg
- Color
- Blue & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
Related Images for "WATSON 425"
More about aspirin / butalbital / caffeine / codeine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 29 Reviews
- Drug class: narcotic analgesic combinations
- FDA Alerts (5)
Consumer resources
- Patient Information
- Butalbital, aspirin, caffeine, and codeine (Advanced Reading)
- Butalbital, Aspirin, Caffeine, and Codeine
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.